FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock™ (belumosudil) 200 mg once daily (QD) for the treatment of adult and pediatric patients… Read More »
‘Zombie deer’ destined for Nevada invasion Officials are trying to prevent ‘zombie deer’ from entering the state of Nevada. ‘Zombie deer’ are creatures that have contracted chronic wasting disease, a highly contagious and often deadly affliction that has ravaged the deer population in an estimated 24 states and two Canadian provinces. Hi Dr. Manny, What… Read More »
Scientists at Harvard-affiliated Massachusetts General Hospital (MGH) have identified a previously unknown biological pathway that promotes chronic inflammation and may help explain why sedentary people have an increased risk for heart disease and strokes. In a study to be published in the November issue of Nature Medicine, MGH scientists and colleagues at several other institutions found… Read More »
A new study in rodents reveals a key protein that may explain why chronic pain persists. The findings may lead to therapeutic agents that could “disrupt the maintenance of pain.”‘ New research in mice may help explain why chronic pain persists in humans. Chronic pain affects over 20% of the adult population in the United… Read More »
Chronic rhinosinusitis is a long-lasting medical condition, usually caused by infection or exposure to irritants, such as allergies, that affects one in seven American adults. Symptoms include nasal obstruction, nasal congestion, nasal drainage, loss of smell and taste, and facial pain and pressure. Some people with chronic rhinosinusitis also develop additional symptoms, such as asthma… Read More »